Article Correctness Is Author's Responsibility: Protection by the malaria vaccine: not only a matter of quantity but also of quality

(Barcelona Institute for Global Health (ISGlobal)) The quantity and quality of antibodies recognizing the end region of the malaria parasite's CSP protein is a good marker of protection by the RTS,S/AS01E vaccine, shows a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by 'la Caixa.' The results provide valuable information for guiding the design of future, more effective vaccines.